EUVIMEDEUVIMED entdecken
Crossref

Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1

Yan Xi, Zhongchao Chi, Xufeng Tao, Xiaohan Zhai, Zirui Zhao, Jiaqi Ren, Shilei Yang, Deshi Dong iD

Environmental Toxicology · 2023-05 · 38 (5) · 1153-1161

DOI: 10.1002/tox.23755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 22.02.2023. Verfasst von Yan Xi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Chemical and Drug Induced Liver Injury, Chronic, Leukemia, Myeloid, Acute, Sirtuin 1. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Scientific Research Project of Department of Education of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical application of doxorubicin is limited because of its potential side effects. The present study examined whether naringin had protective actions on doxorubicin‐induced liver injury. Male BALB/c mice and alpha mouse liver 12 (AML‐12) cells were used in this paper. The results showed that AML‐12 cells treated with naringin significantly reduced cell injury, reactive oxygen species release and apoptosis level; Moreover, naringin notably alleviated liver injury by decreasing aspartate transaminase, alanine transaminase and malondialdehyde, and increasing superoxide dismutase, glutathione and catalase levels. Mechanism researches indicated that naringin increased the expression levels of sirtuin 1 (SIRT1), and inhibited the downstream inflammatory, apoptotic and oxidative stress signaling pathways. Further validation was obtained by knocking down SIRT1 in vitro, which proved the effects of naringin on doxorubicin‐induced liver injury. Therefore, naringin is a valuable lead compound for preventing doxorubicin‐induced liver damage by reducing oxidative stress, inflammation, and apoptosis via up‐regulation of SIRT1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryChemical and Drug Induced Liver Injury, ChronicLeukemia, Myeloid, AcuteSirtuin 1AnimalsMaleMiceApoptosisDoxorubicinInflammationLiverOxidative StressUp-RegulationFlavanones

Stichwörter der Autor:innen

NaringinSIRT1doxorubicinliver injury

Substanzen

DoxorubicinnaringinSirt1 protein, mouseSirtuin 1Flavanones

Autor:innen und Institutionen

  • Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Department of Pharmacy, Third People's Hospital of Dalian, Dalian, China.

ORCID-Profile: Deshi Dong

Förderung

  • Scientific Research Project of Department of Education of Liaoning Province

Zitieren

APA

Xi, Y., Chi, Z., Tao, X., Zhai, X., Zhao, Z., Ren, J., Yang, S., & Dong, D. (2023). Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1. Environmental Toxicology, 38(5), 1153-1161. https://doi.org/10.1002/tox.23755

Vancouver

Xi Y, Chi Z, Tao X, Zhai X, Zhao Z, Ren J, et al. Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1. Environmental Toxicology. 2023;38(5):1153-1161. doi:10.1002/tox.23755

BibTeX
@article{Xi2023,
  author = {Xi, Yan and Chi, Zhongchao and Tao, Xufeng and Zhai, Xiaohan and Zhao, Zirui and Ren, Jiaqi and Yang, Shilei and Dong, Deshi},
  title = {Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1},
  journal = {Environmental Toxicology},
  year = {2023},
  volume = {38},
  number = {5},
  pages = {1153--1161},
  doi = {10.1002/tox.23755}
}
Kostenlos starten →